Literature DB >> 16955657

End-of-Life decision making for nursing home residents with dementia: a survey of nursing home social services staff.

Debra Lacey1.   

Abstract

The purpose of this survey was to describe nursing home social services staff roles and perceptions related to end-of-life medical decision making for nursing home residents in endstage dementia. Using a self-designed questionnaire, 138 nursing home social services staff from across New York State answered questions about advance directives, medical interventions, and comfort levels with withholding and withdrawing of treatment. Results showed a high degree of involvement in advance directive discussions, problems in the implementation of advance directives, and wide variation in comfort levels with treatment issues. Results of this study indicate areas of need for further research and training of nursing home social services staff.

Entities:  

Mesh:

Year:  2006        PMID: 16955657     DOI: 10.1093/hsw/31.3.189

Source DB:  PubMed          Journal:  Health Soc Work        ISSN: 0360-7283


  4 in total

1.  Discussion as a factor in racial disparity in advance directive completion at nursing home admission.

Authors:  Shayna E Rich; Ann L Gruber-Baldini; Charlene C Quinn; Sheryl I Zimmerman
Journal:  J Am Geriatr Soc       Date:  2009-01       Impact factor: 5.562

2.  Nursing home staff perspectives on adoption of an innovation in goals of care communication.

Authors:  Latarsha Chisholm; Sheryl Zimmerman; Cherie Rosemond; Eleanor McConnell; Bryan J Weiner; Feng-Chang Lin; Laura Hanson
Journal:  Geriatr Nurs       Date:  2017-08-31       Impact factor: 2.361

Review 3.  Burden and Management of Multidrug-Resistant Organisms in Palliative Care.

Authors:  Rupak Datta; Manisha Juthani-Mehta
Journal:  Palliat Care       Date:  2017-12-19

Review 4.  Social workers' involvement in advance care planning: a systematic narrative review.

Authors:  Chong-Wen Wang; Cecilia L W Chan; Amy Y M Chow
Journal:  BMC Palliat Care       Date:  2017-07-10       Impact factor: 3.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.